GCP
TBPH icon

GSA Capital Partners’s Theravance Biopharma TBPH Stock Holding History

GSA Capital Partners’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58,379
Closed -$1.09M – 2147
2025
Q4 		$1.09M Sell
58,379
-33,802
-37% -$561K 0.09% 315
2025
Q3 		$1.35M Sell
92,181
-45,770
-33% -$578K 0.11% 233
2025
Q2 		$1.52M Sell
137,951
-44,399
-24% -$432K 0.11% 230
2025
Q1 		$1.63M Buy
182,350
+19,363
+12% +$180K 0.15% 136
2024
Q4 		$1.53M Sell
162,987
-66,793
-29% -$608K 0.11% 183
2024
Q3 		$1.85M Buy
229,780
+25,691
+13% +$223K 0.14% 151
2024
Q2 		$1.73M Buy
+204,089
New +$1.84M 0.12% 207
2024
Q1 		– Sell
-77,070
Closed -$866K – 1959
2023
Q4 		$866K Sell
77,070
-248,915
-76% -$2.51M 0.07% 464
2023
Q3 		$2.81M Buy
325,985
+306,064
+1,536% +$2.95M 0.24% 41
2023
Q2 		$206K Sell
19,921
-85,342
-81% -$942K 0.02% 1253
2023
Q1 		$1.14M Buy
105,263
+47,686
+83% +$504K 0.11% 252
2022
Q4 		$646K Buy
+57,577
New +$605K 0.08% 440
2022
Q3 		– Sell
-114,646
Closed -$1.04M – 1850
2022
Q2 		$1.04M Buy
114,646
+65,190
+132% +$601K 0.16% 133
2022
Q1 		$473K Buy
+49,456
New +$485K 0.06% 569
2020
Q4 		– Sell
-13,965
Closed -$206K – 1584
2020
Q3 		$206K Buy
+13,965
New +$262K 0.03% 992
2019
Q4 		– Sell
-10,745
Closed -$209K – 1720
2019
Q3 		$209K Buy
+10,745
New +$217K 0.03% 1153

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GSA Capital Partners's TBPH Position: Q1 2026 in Review

GSA Capital Partners sold out of Theravance Biopharma (TBPH) in Q1 2026, closing a stake of 58,379 shares — an estimated $1.09M sold.

GSA Capital Partners first reported a position in TBPH in Q3 2019 and held it in 16 quarters. The position peaked at $2.81M in Q3 2023. 174 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • GSA Capital Partners reported no remaining Theravance Biopharma position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 58,379 Theravance Biopharma shares in Q1 2026, an estimated $1.09M.
  • GSA Capital Partners first reported a position in Theravance Biopharma in Q3 2019 and held it in 16 quarters.
  • GSA Capital Partners's Theravance Biopharma position peaked at $2.81M in Q3 2023.
  • 174 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.